497 related articles for article (PubMed ID: 22351693)
1. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
[TBL] [Abstract][Full Text] [Related]
2. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
[TBL] [Abstract][Full Text] [Related]
3. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Umbricht CB; Conrad GT; Clark DP; Westra WH; Smith DC; Zahurak M; Saji M; Smallridge RC; Goodman S; Zeiger MA
Clin Cancer Res; 2004 Sep; 10(17):5762-8. PubMed ID: 15355904
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; McMillan A
Cancer; 2006 Jun; 106(12):2592-7. PubMed ID: 16688775
[TBL] [Abstract][Full Text] [Related]
5. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
[TBL] [Abstract][Full Text] [Related]
6. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
Bartolazzi A; Orlandi F; Saggiorato E; Volante M; Arecco F; Rossetto R; Palestini N; Ghigo E; Papotti M; Bussolati G; Martegani MP; Pantellini F; Carpi A; Giovagnoli MR; Monti S; Toscano V; Sciacchitano S; Pennelli GM; Mian C; Pelizzo MR; Rugge M; Troncone G; Palombini L; Chiappetta G; Botti G; Vecchione A; Bellocco R;
Lancet Oncol; 2008 Jun; 9(6):543-9. PubMed ID: 18495537
[TBL] [Abstract][Full Text] [Related]
8. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of the candidate microRNAs in thyroid fine-needle aspiration biopsy (FNAB) samples.
Mahmoudian-Sani MR; Amrollahi-Sharifabadi M; Taheri A; Hosseini SM; Tahmasebi K; Mobini GR
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32167927
[TBL] [Abstract][Full Text] [Related]
10. Preoperative detection of malignancy in fine-needle aspiration cytology (FNAC) smears with indeterminate cytology (Bethesda III, IV) by a combined molecular classifier.
Titov S; Demenkov PS; Lukyanov SA; Sergiyko SV; Katanyan GA; Veryaskina YA; Ivanov MK
J Clin Pathol; 2020 Nov; 73(11):722-727. PubMed ID: 32213552
[TBL] [Abstract][Full Text] [Related]
11. An updated audit of fine needle aspiration cytology procedure of solitary thyroid nodule.
Bukhari MH; Niazi S; Hanif G; Qureshi SS; Munir M; Hasan M; Naeem S
Diagn Cytopathol; 2008 Feb; 36(2):104-12. PubMed ID: 18181183
[TBL] [Abstract][Full Text] [Related]
12. Nondiagnostic thyroid fine needle aspiration cytology: outcome in surgical treatment.
Tamez-Pérez HE; Gutiérrez-Hermosillo H; Forsbach-Sánchez G; Gómez-de Ossio MD; González-González G; Guzmán-López S; Tamez-Peña AL; Mora-Torres NE; González-Murillo EA
Rev Invest Clin; 2007; 59(3):180-3. PubMed ID: 17910409
[TBL] [Abstract][Full Text] [Related]
13. Does routine consultation of thyroid fine-needle aspiration cytology change surgical management?
Tan YY; Kebebew E; Reiff E; Caron NR; Ogilvie JB; Duh QY; Clark OH; Ljung BM; Miller T
J Am Coll Surg; 2007 Jul; 205(1):8-12. PubMed ID: 17617326
[TBL] [Abstract][Full Text] [Related]
14. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
Freitas BC; Cerutti JM
Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
[TBL] [Abstract][Full Text] [Related]
15. Repeat thyroid nodule fine-needle aspiration in patients with initial benign cytologic results.
Flanagan MB; Ohori NP; Carty SE; Hunt JL
Am J Clin Pathol; 2006 May; 125(5):698-702. PubMed ID: 16707370
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules.
Lappinga PJ; Kip NS; Jin L; Lloyd RV; Henry MR; Zhang J; Nassar A
Cancer Cytopathol; 2010 Oct; 118(5):287-97. PubMed ID: 20597139
[TBL] [Abstract][Full Text] [Related]
17. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
18. Human telomerase reverse transcriptase (hTERT) gene expression in thyroid neoplasms.
Saji M; Xydas S; Westra WH; Liang CK; Clark DP; Udelsman R; Umbricht CB; Sukumar S; Zeiger MA
Clin Cancer Res; 1999 Jun; 5(6):1483-9. PubMed ID: 10389936
[TBL] [Abstract][Full Text] [Related]
19. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
[TBL] [Abstract][Full Text] [Related]
20. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
Daniels GH
Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
[No Abstract] [Full Text] [Related]
[Next] [New Search]